Cyberonics to help patients with life-threatening depression
This article was originally published in Clinica
Recovering from its shock at the US FDA's recent decision not to approve its pacemaker-like device as a treatment for depression, Cyberonics is taking the steps needed to at least make the product available to patients with a life-threatening form of the condition.
You may also be interested in...
Nina Daily, chief marketing officer at the Professional Beauty Association since July 2018, will succeed Steve Sleeper as executive director at the end of June when Sleeper retires. More cosmetics industry appointments.
Third round of orders would give the US all the vaccine it needs from the existing mRNA products, taking pressure off AstraZeneca is it experiences manufacturing challenges and the EU considers export restrictions to ensure it gets enough vaccine.
Listerine mouthwash drove J&J’s oral care sales up 11.4% in the fourth quarter. Tylenol for adults was the star of its OTC drug business but weakness of children’s Tylenol products and other OTCs led to flat sales.